Next, we analyzed the ERAP2 expression in pancreatic cancer by the GEPIA database and found that ERAP2 was significantly overexpressed in pancreatic cancer samples, which further demonstrated the cancer-promoting effect of ERAP2 (Figure 5C). This evidence concerns the gene ERAP2 and familial pancreatic carcinoma.